Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make

4 hours ago

What Maven CEO Kate Ryder tells her kids every day amid AI education threat

4 hours ago

Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost

5 hours ago

UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs

1 day ago

Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock

2 days ago

Jim Cramer week ahead: Bank earnings, ASML and TSMC

2 days ago

For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come

5 days ago

Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday

7 days ago

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

7 days ago

Jim Cramer says Grail can run higher as FDA decision on Galleri nears

7 days ago

Russian lab worker's suspected plague death leaves experts puzzled

8 days ago

Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk

8 days ago

AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos

8 days ago

Russian lab worker dies amid plague reports. Here's what we know

9 days ago

Russia hospitalizes almost 200 people after death from plague: Reports

9 days ago

BioMarin reports five-year Pompe disease data showing durable motor function

12 days ago

Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s

12 days ago

Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion

12 days ago

De-risking rare disease drug development

12 days ago

Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock

4 days ago

$942 million: Insurer points finger at AI as suspect hospital charges appear

13 days ago

Grindr expands beyond dating with $250 million PurposeMed acquisition

13 days ago

Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial

14 days ago

Novo's Wegovy pill improves weight loss after people switch from injections

14 days ago

White House moves to block $810 million in funding through pocket rescission

18 days ago

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

19 days ago

NIH cuts delayed a cancer trial. Patients lost time they didn't have

19 days ago

Why we like Starbucks' latest turnaround move — plus, two more wins for Eli Lilly

4 days ago

Novo's new strategy hinges on something it can't manufacture: investor trust

20 days ago

Trump administration removes around 760,000 Obamacare enrollments

20 days ago

Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage

22 days ago

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo

23 days ago